CN Patent
CN102001962B — N-[8-(2-羟基苯甲酰基)氨基]辛酸一钠的晶体的多晶
Assigned to Emisphere Technologies Inc · Expires 2013-04-03 · 13y expired
What this patent protects
本发明涉及N-[8-(2-羟基苯甲酰基)氨基]辛酸一钠的晶体的多晶,包括SNAC的两种水合物、甲醇溶剂合物和乙醇溶剂合物。更具体的说,本发明提供了SNAC的六种多晶型(下文称作晶型I-VI)。本发明还提供了SNAC的非晶型。
USPTO Abstract
本发明涉及N-[8-(2-羟基苯甲酰基)氨基]辛酸一钠的晶体的多晶,包括SNAC的两种水合物、甲醇溶剂合物和乙醇溶剂合物。更具体的说,本发明提供了SNAC的六种多晶型(下文称作晶型I-VI)。本发明还提供了SNAC的非晶型。
Drugs covered by this patent
- Ozempic (semaglutide) · Novo Nordisk
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.